By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Remedent, Inc.

Remedent, Inc. (REMI)

OTC Currency in USD
$0.01
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$199.96K
Market Cap
-0.72
P/E Ratio (TTM)
Forward Dividend Yield
$0.01 - $0.06
52 Week Range

REMI Stock Price Chart

Explore Remedent, Inc. interactive price chart. Choose custom timeframes to analyze REMI price movements and trends.

REMI Company Profile

Discover essential business fundamentals and corporate details for Remedent, Inc. (REMI) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

1 Mar 2006

Employees

3.00

CEO

Guy De Vreese

Description

Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. It also provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. In addition, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice, which enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Further, it provides dental implant solutions and treatment concepts. The company sells its products to dental professionals in approximately 30 countries, including Asia, Europe, the Middle East, Canada, and the United States through its internal sales force and third party distributors. The company was founded in 1986 and is headquartered in Ghent, Belgium.

REMI Financial Timeline

Browse a chronological timeline of Remedent, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 31 Dec 2023

EPS came in at $0.00 , while revenue for the quarter reached $329.83K .

Earnings released on 16 Feb 2021

EPS came in at $0.00 , while revenue for the quarter reached $337.47K .

Earnings released on 16 Nov 2020

EPS came in at $0.00 , while revenue for the quarter reached $321.92K .

REMI Stock Performance

Access detailed REMI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run